These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
881 related items for PubMed ID: 16287615
1. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets. Koda M, Banno Y, Naganawa T. Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615 [Abstract] [Full Text] [Related]
2. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen. Diaz-Ricart M, Palomo M, Fuste B, Lopez-Vilchez I, Carbo C, Perez-Pujol S, White JG, Escolar G. Thromb Res; 2008 Dec; 121(6):873-83. PubMed ID: 17904203 [Abstract] [Full Text] [Related]
3. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis. Coffey MJ, Jarvis GE, Gibbins JM, Coles B, Barrett NE, Wylie OR, O'Donnell VB. Circ Res; 2004 Jun 25; 94(12):1598-605. PubMed ID: 15142951 [Abstract] [Full Text] [Related]
4. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Ozaki H, Ishii K, Arai H, Horiuchi H, Kawamoto T, Suzuki H, Kita T. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):873-8. PubMed ID: 11027562 [Abstract] [Full Text] [Related]
5. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Kim SD, Lee IK, Lee WM, Cho JY, Park HJ, Oh JW, Park SC, Kim SK, Kwak YS, Yun BS, Rhee MH. Eur J Pharmacol; 2008 Apr 28; 584(2-3):361-7. PubMed ID: 18313047 [Abstract] [Full Text] [Related]
6. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock. Tsen A, Kirschenbaum LA, LaRow C, Khan R, Kurtz S, Bansal S, Astiz ME. Shock; 2009 Feb 28; 31(2):120-4. PubMed ID: 18636042 [Abstract] [Full Text] [Related]
7. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction. Liao CH, Cheng JT, Teng CM. Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105 [Abstract] [Full Text] [Related]
8. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation. Kubota Y, Arai T, Tanaka T, Yamaoka G, Kiuchi H, Kajikawa T, Kawanishi K, Ohnishi H, Yamaguchi M, Takahara J, Irino S. Stem Cells; 1996 Jul 05; 14(4):439-44. PubMed ID: 8843545 [Abstract] [Full Text] [Related]
9. Tyrosine kinase blockers: new platelet activation inhibitors. Rendu F, Eldor A, Grelac F, Levy-Toledano S, Levitzki A. Blood Coagul Fibrinolysis; 1990 Dec 05; 1(6):713-6. PubMed ID: 2133252 [Abstract] [Full Text] [Related]
10. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide. Ward PA, Cunningham TW, McCulloch KK, Phan SH, Powell J, Johnson KJ. Lab Invest; 1988 Jan 05; 58(1):37-47. PubMed ID: 2826882 [Abstract] [Full Text] [Related]
11. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Nakashima S, Koike T, Nozawa Y. Mol Pharmacol; 1991 Apr 05; 39(4):475-80. PubMed ID: 2017148 [Abstract] [Full Text] [Related]
12. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen. Hargreaves PG, Licking EF, Sargeant P, Sage SO, Barnes MJ, Farndale RW. Thromb Haemost; 1994 Oct 05; 72(4):634-42. PubMed ID: 7878644 [Abstract] [Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY, Hsieh PW, Wu YC, Wu CC. Biochem Pharmacol; 2007 Aug 15; 74(4):601-11. PubMed ID: 17601492 [Abstract] [Full Text] [Related]
14. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib. Diaz-Ricart M, Fuste B, Estebanell E, Tonda R, Lozano M, Escolar G, Jamieson G, Ordinas A. Platelets; 2005 Dec 15; 16(8):453-61. PubMed ID: 16287612 [Abstract] [Full Text] [Related]
15. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591 [Abstract] [Full Text] [Related]
16. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor. Wang WY, Wu YC, Wu CC. Mol Pharmacol; 2006 Oct 15; 70(4):1380-9. PubMed ID: 16837624 [Abstract] [Full Text] [Related]
17. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Martinson EA, Scheible S, Marx-Grunwitz A, Presek P. Thromb Haemost; 1998 Dec 15; 80(6):976-81. PubMed ID: 9869170 [Abstract] [Full Text] [Related]
18. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation. Shen EC, Chou TC, Gau CH, Tu HP, Chen YT, Fu E. Clin Oral Implants Res; 2006 Oct 15; 17(5):572-8. PubMed ID: 16958699 [Abstract] [Full Text] [Related]
19. Detection of activated platelets and platelet-leukocyte aggregates in horses. Weiss DJ, Evanson OA. Am J Vet Res; 1997 Aug 15; 58(8):823-7. PubMed ID: 9256963 [Abstract] [Full Text] [Related]
20. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S. Blood Coagul Fibrinolysis; 2008 Sep 15; 19(6):557-67. PubMed ID: 18685439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]